Works matching IS 18129269 AND DT 2022 AND VI 44 AND IP 1

Results: 13

DANYLO FISHELEVYCH GLUZMAN (1936‒2022).

Published in:: Experimental Oncology, 2022, v. 44, n. 1, p. 87
Publication type:: Article

RAPID LOW-COST DETECTION OF TYPE 2 CALR MUTATION BY ALLELE-SPECIFIC RT-PCR FOR DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 83

By:

Dybkov, M. V.;
Zavelevich, M. P.;
Gluzman, D. F.;
Telegeev, G. D.

Publication type:

Article

EVALUATION OF THE EFFICIENCY OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE FOR THE PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY ACCORDING TO THE TOTAL NEUROPATHY SCORE.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 75, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17257

By:

Holotiuk, I. S.;
Kryzhanivska, A. Ye.;
Holotiuk, S. I.;
Maliborska, S. V.;
Holotiuk, V. V.

Publication type:

Article

LONG-TERM RADICAL PROSTATECTOMY ONCOLOGIC OUTCOMES IN PATIENTS WITH CLINICALLY LOCALLY ADVANCED PROSTATE CANCER: A SINGLE-CENTER STUDY.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 67, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17436

By:

Grygorenko, V.;
Afanasiev, Ye;
Danylets, R.;
Vikarchuk, M.;
Kosyuchno, M.;
Pasichnyk, S.

Publication type:

Article

EVALUATION OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY: ROLE OF CARDIAC BIOMARKERS.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 60, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17496

By:

Moghaddam, Zhaleh Karimi;
Rostami, Mina;
Zeraatchi, Alireza;
Abadi, Hamidreza Fallah;
Karamitanha, Farzaneh;
Amirmoghaddami, Hamidreza

Publication type:

Article

NOD2 C.3019-3020INSC AND C.2104C>T GENE VARIANTS AMONG PATIENTS FROM WESTERN UKRAINE WITH CROHN'S DISEASE AND COLORECTAL CANCER.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 52, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17305

By:

Lozynska, L.;
Pinyazhko, R.;
Lozynska, M.;
Plawski, A.;
Makukh, H.;
Lukavetskyy, O.;
Grzegotsky, M.;
Pinyazhko, O.

Publication type:

Article

DIFFERENTIAL EXPRESSION PATTERN OF AIP, UCKL1, AND PKN1 GENES IN PROSTATE CANCER PATIENTS.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 47, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17380

By:

Kovalevska, L.;
Zadvornyj, T.;
Lukianova, N.;
Kashuba, E.

Publication type:

Article

EXPRESSION OF MARKERS OF BONE TISSUE REMODELING IN BREAST CANCER AND PROSTATE CANCER CELLS IN VITRO.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 39, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17354

By:

Lukianova, N.;
Zadvornyi, T.;
Kashuba, E.;
Borikun, T.;
Mushii, О.;
Chekhun, V.

Publication type:

Article

ADAPTOR PROTEIN RUK/CIN85 REGULATES REDOX BALANCE IN 4T1 MOUSE BREAST CANCER CELLS EXPOSED TO PLASMIN(OGEN).

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 31, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17241

By:

Horak, I. R.;
Latyshko, N. V.;
Hudkova, O. O.;
Tokarchuk, K. O.;
Kishko, T. O.;
Yusova, O. I.;
Drobot, L. B.;
Tykhomyrov, A. A.

Publication type:

Article

A LONG-TERM 10G-HYPERGRAVITY EXPOSURE PROMOTES CELL-CELL CONTACTS AND REDUCES ADHESIVENESS TO A SUBSTRATE, MIGRATION, AND INVASIVENESS OF MCF-7 HUMAN BREAST CANCER CELLS.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 23, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17270

By:

Kannan, S.;
Shailesh, H.;
Mohamed, H.;
Souchelnytskyi, N.;
Souchelnytskyi, S.

Publication type:

Article

ON THE ORIGIN OF LUNG CANCER DEVELOPMENT.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 17, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17227

By:

Bolgova, L. S.;
Tuganova, T. N.;
Alekseenko, O. I.;
Ponomarenko, A. A.

Publication type:

Article

CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 7, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17411

By:

Kumar, M.;
Sarkar, A.

Publication type:

Article

THERAPEUTIC TARGETING OF MOLECULAR PATHWAYS IN COLORECTAL CANCER.

Published in:

Experimental Oncology, 2022, v. 44, n. 1, p. 2, doi. 10.32471/exp-oncology.2312-8852.vol-44-no-1.17455

By:

Ebru Nur, A.

Publication type:

Article